Scientific Advisory Board

ANDREW D. ZELENETZ, MD, PhD

Chair
Memorial Sloan Kettering Cancer Center, New York

Andrew D. Zelenetz, MD, PhD, is the Medical Director of Quality Informatics at Memorial Sloan Kettering Cancer Center in New York.  Prior to that, he had held the positions of Vice Chair, Medical Informatics from January 2013 to May 2016 and Chief, Lymphoma Service in the Division of Hematology/Oncology at MSKCC from 1994-December 2012.  He is also a Professor of Medicine at Weill Cornell Medical College. Dr. Zelenetz was elected Chair-Elect of the SAB in 2017, assuming the Chair in 2019.

He has helped develop several agents now approved to treat lymphoma — including 131I-tosituomab/tositumomab, bortezomib, and pralatrexate — and through clinical studies he is evaluating the benefits of novel combinations of agents. Dr. Zelenetz has also published more than 100 papers on lymphoma research in journals such as Blood, Journal of Clinical Oncology and Clinical Cancer Research.

SONALI M. SMITH MD
Chair-Elect
The University of Chicago

RANJANA ADVANI, MD
Stanford University School of Medicine

ASH A. ALIZADEH, MD, PhD
Stanford University School of Medicine

STEPHEN ANSELL, MD, PhD
Mayo Clinic, Rochester

KRISTIE A. BLUM, MD
Winship Cancer Institute of Emory University

CATHERINE BOLLARD, MD, MBChB
George Washington University
Children’s National Medical Center

JENNIFER BROWN, MD
Dana-Farber Cancer Institute

JAMES R. CERHAN, MD, PhD
Mayo Clinic, Rochester

ETHEL CESARMAN, MD, PhD
NewYork-Presbyterian Hospital
Weill Cornell Medicine

BRUCE D. CHESON, MD, FACP, FAAAS, FASCO
Past Chair, 2010-2012

MORTON COLEMAN, MD
Chair, Medical Affiliates Board
NewYork-Presbyterian Hospital
Weill Cornell Medicine

SANDEEP DAVE, MD, MS
Duke University

KIERON M. DUNLEAVY, MD
George Washington University
GW Cancer Center

KOJO S.J. ELENITOBA-JOHNSON, MD
University of Pennsylvania
Perelman School of Medicine

ANDREW M. EVENS, DO, MSc, FACP
Rutgers Cancer Institute of New Jersey

CHRISTOPHER R. FLOWERS, MD, MS
The University of Texas MD Anderson Cancer Center

JONATHAN W. FRIEDBERG, MD, MMSc
University of Rochester
James P. Wilmot Cancer Institute

LEO I. GORDON, MD, FACP
Past Chair, 2015-2017
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

THOMAS M. HABERMANN, MD
Immediate Past Chair, 2017-2019
Mayo Clinic, Rochester

STEVEN M. HORWITZ, MD
Memorial Sloan Kettering Cancer Center

ERIC D. HSI, MD
Wake Forest

BRAD S. KAHL, MD
Washington University School of Medicine

KARA KELLY, MD
Roswell Park Comprehensive Cancer Center
University at Buffalo Jacobs School of Medicine

ANN S. LACASCE, MD
Harvard Medical School
Dana-Farber Cancer Institute

JOHN P. LEONARD, MD
Past Chair, 2012-2015
NewYork-Presbyterian Hospital
Weill Cornell Medicine

BRIAN K. LINK, MD
University of Iowa

IZIDORE S. LOSSOS, MD
University of Miami Health System
Sylvester Comprehensive Cancer Center

PETER MARTIN, MD
Weill Cornell Medicine

ARI MELNICK, MD
NewYork-Presbyterian Hospital
Weill Cornell Medicine

LINDSAY M. MORTON, PhD
National Cancer Institute

LAURA PASQUALUCCI, MD
Columbia University
H. Irving Comprehensive Cancer Center

BARBARA PRO, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

KANTI R. RAI, MD, BS
Hofstra Northwell School of Medicine

LISA RIMSZA, MD
Mayo Clinic, Arizona

KERRY SAVAGE, MD
BC Cancer, Vancouver

DAVID SCOTT, MBChB, PhD
BC Cancer, Vancouver

LAURIE SEHN, MD, MPH
BC Cancer, Vancouver

MARGARET SHIPP, MD
Harvard Medical School
Dana-Farber Cancer Institute

EDUARDO M. SOTOMATOR, MD

CHRISTIAN STEIDL, MD
BC Cancer, Vancouver

JOHN M. TIMMERMAN, MD
UCLA Oncology Center

SVEN de VOS, MD, PhD
UCLA Jonsson Comprehensive Cancer Center

HANS-GUIDO WENDEL, MD
Memorial Sloan Kettering Cancer Center

MICHAEL E. WILLIAMS, MD, ScM
University of Virginia Cancer Center

Members Emeritus

Download the full list of LRF Scientific Advisory Board.

Learn more about our past Scientific Advisory Board Chairs.